Income Statement - Maze Therapeutics, Inc. (MAZE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total revenue | 0.00 | 167.50 | 0.00 | 0.00 |
| Cost of revenue | 2.40 | 3.30 | 4.09 | 3.82 |
| Gross profit | -2.40 | 167.50 | -4.09 | -3.82 |
| Total operating expenses | 140.50 | 109.91 | 98.55 | 111.03 |
| Operating income | -142.90 | 57.59 | -98.55 | -111.03 |
| Non-operating income (net) | 11.78 | -4.18 | -1.86 | -3.91 |
| Income before tax | -131.12 | 53.40 | -100.42 | -114.94 |
| Income tax expense | 1.17 | |||
| Net income | -131.12 | 52.23 | -100.42 | -114.94 |
Show Quarterly Income Statement
Income Statement - Maze Therapeutics, Inc. (MAZE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 | 165.00 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 0.44 | 0.50 | 0.65 | 0.68 | 0.71 | 0.79 | 0.95 | 0.98 | 1.00 | ||
| Gross profit | 19.56 | -0.50 | -0.65 | -0.68 | -0.71 | 2.50 | 165.00 | -0.95 | -0.98 | -1.00 | |
| Total operating expenses | 46.11 | 37.56 | 32.97 | 35.83 | 35.40 | 29.73 | 26.73 | 25.45 | 28.01 | 23.05 | 25.23 |
| Operating income | -26.55 | -38.06 | -32.97 | -36.47 | -35.40 | -29.73 | -24.23 | 139.56 | -28.01 | -23.05 | -25.23 |
| Non-operating income (net) | 2.35 | 3.49 | 2.88 | 2.80 | 2.62 | -0.13 | -0.80 | 1.23 | -4.48 | -3.53 | 0.48 |
| Income before tax | -24.21 | -34.57 | -30.09 | -33.68 | -32.79 | -29.85 | -25.03 | 140.78 | -32.49 | -26.58 | -24.75 |
| Income tax expense | -0.28 | -0.28 | 1.73 | ||||||||
| Net income | -24.21 | -34.57 | -30.09 | -33.68 | -32.79 | -29.58 | -24.75 | 139.06 | -32.49 | -26.58 | -24.75 |